Related Experiment Video
Updated: May 9, 2026

10:54
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
Cyclotron Production of (99m)Tc using (100)Mo2C targets
Vernal N Richards1, Efrem Mebrahtu, Suzanne E Lapi
1Department of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Nuclear Medicine and Biology
|July 30, 2013
Summary
This study introduces molybdenum-100 carbide ((100)Mo2C) as a novel target for producing technetium-99m (99mTc) via the (100)Mo (p,2n)99mTc reaction. High yields and efficient recovery demonstrate its potential for medical isotope production.
Area of Science:
- Nuclear Chemistry
- Radiochemistry
- Medical Isotope Production
Background:
- Technetium-99m (99mTc) is a crucial radionuclide for diagnostic imaging.
- Efficient production methods for 99mTc are continuously sought to meet clinical demand.
- Molybdenum-100 (100Mo) is a promising precursor for 99mTc production.
Purpose of the Study:
- To investigate the (100)Mo (p,2n)99mTc reaction using molybdenum-100 carbide ((100)Mo2C) as a target material.
- To evaluate the suitability of (100)Mo2C for 99mTc production on a medical cyclotron.
- To assess the efficiency of thermo-chromatography for 99mTc separation and isolation.
Main Methods:
- Synthesis of (100)Mo2C from (100)MoO3.
- Irradiation of the (100)Mo2C target with protons on a medical cyclotron.
- Separation and isolation of 99mTc using high-temperature thermo-chromatography.
- Radiochemical purity assessment and labeling with MDP for imaging.
Main Results:
- The (100)Mo (p,2n)99mTc reaction was successfully performed using (100)Mo2C for the first time.
- Activity yields for 99mTc averaged 84% of theoretical yields.
- Percent recovery of the precursor MoO3 was high at 85%, indicating good target material lifecycle.
- Produced 99mTc was radio-chemically pure and suitable for labeling.
Conclusions:
- Molybdenum-100 carbide ((100)Mo2C) is an effective target material for cyclotron-based 99mTc production.
- Thermo-chromatography is a viable method for efficient 99mTc separation and isolation from the target.
- This method offers a promising route for reliable 99mTc supply for medical imaging.
Related Concept Videos
Nuclear Transmutation
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed protons being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
